In addition, one study found a correlation between a high expression of SLAMF8/CD353, tumor necrosis factor (TNF), and lymphocyte infiltration with a poor response to therapy in postmenopausal estrogen receptor (ER)+ breast cancer (23). This evidence concerns the gene ESR1 and breast carcinoma.